Health ❯ Obesity

Weight Loss Treatments

GLP-1 Drugs Pharmaceuticals GLP-1 Agonists Medications GLP-1 Receptor Agonists Semaglutide Wegovy Prescription Drugs Clinical Research Injectable Therapies GLP-1 Medicines Market Penetration Drug Treatments Drug Development Medication Efficacy Pharmacological Treatments Patient Experiences Pharmaceutical Interventions Clinical Trials Zepbound Pharmaceutical Products Drug Efficacy GLP-1 Hormones Anti-Obesity Drugs

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

The deal trades steep list-price cuts for expedited FDA reviews and temporary tariff relief.

Novo Nordisk Survey Finds Wegovy Users Report Sharp Drop in ‘Food Noise’

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

Guidelines Tie Diet and Exercise to GLP-1 Drug Success as India Launches Treatments